Cargando…
Reply to Yan and Muller, “Remdesivir for COVID-19: Why Not Dose Higher?”
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society for Microbiology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097414/ https://www.ncbi.nlm.nih.gov/pubmed/33558289 http://dx.doi.org/10.1128/AAC.00085-21 |
| _version_ | 1783688346648707072 |
|---|---|
| author | Juneja, Kavita Humeniuk, Rita Porter, Danielle Cao, Huyen Feng, Joy |
| author_facet | Juneja, Kavita Humeniuk, Rita Porter, Danielle Cao, Huyen Feng, Joy |
| author_sort | Juneja, Kavita |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8097414 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | American Society for Microbiology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80974142021-05-10 Reply to Yan and Muller, “Remdesivir for COVID-19: Why Not Dose Higher?” Juneja, Kavita Humeniuk, Rita Porter, Danielle Cao, Huyen Feng, Joy Antimicrob Agents Chemother Letter to the Editor American Society for Microbiology 2021-03-18 /pmc/articles/PMC8097414/ /pubmed/33558289 http://dx.doi.org/10.1128/AAC.00085-21 Text en Copyright © 2021 American Society for Microbiology. https://doi.org/10.1128/ASMCopyrightv1All Rights Reserved (https://doi.org/10.1128/ASMCopyrightv1) . |
| spellingShingle | Letter to the Editor Juneja, Kavita Humeniuk, Rita Porter, Danielle Cao, Huyen Feng, Joy Reply to Yan and Muller, “Remdesivir for COVID-19: Why Not Dose Higher?” |
| title | Reply to Yan and Muller, “Remdesivir for COVID-19: Why Not Dose Higher?” |
| title_full | Reply to Yan and Muller, “Remdesivir for COVID-19: Why Not Dose Higher?” |
| title_fullStr | Reply to Yan and Muller, “Remdesivir for COVID-19: Why Not Dose Higher?” |
| title_full_unstemmed | Reply to Yan and Muller, “Remdesivir for COVID-19: Why Not Dose Higher?” |
| title_short | Reply to Yan and Muller, “Remdesivir for COVID-19: Why Not Dose Higher?” |
| title_sort | reply to yan and muller, “remdesivir for covid-19: why not dose higher?” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097414/ https://www.ncbi.nlm.nih.gov/pubmed/33558289 http://dx.doi.org/10.1128/AAC.00085-21 |
| work_keys_str_mv | AT junejakavita replytoyanandmullerremdesivirforcovid19whynotdosehigher AT humeniukrita replytoyanandmullerremdesivirforcovid19whynotdosehigher AT porterdanielle replytoyanandmullerremdesivirforcovid19whynotdosehigher AT caohuyen replytoyanandmullerremdesivirforcovid19whynotdosehigher AT fengjoy replytoyanandmullerremdesivirforcovid19whynotdosehigher |